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Genetically Susceptible Subgroups
by Louise C. Strong*
In establishing "safe" standards for all with re-
spect to environmental carcinogenesis, one must
consider the heterogeneity ofman. Although cancer
is considered primarily an environmental disease,
there is a wide range of genetic-environmental in-
teraction which ultimately influences the develop-
ment of malignant disease.
Considerations of subgroups susceptible to en-
vironmental carcinogenesis requires consideration
of mechanisms of carcinogenesis. It appears that
most carcinogens are mutagens, and that car-
cinogenesis may be viewed as a multistage process.
Ifmutation is an essential step in the carcinogenic
pathway and more than one step is required, then
susceptibility to malignancy following mutagen ex-
posure may be affected either by variation in the
probability ofmutation orvariation in the numberof
necessary mutagenic events. In addition, the prob-
ability of malignancy following a mutational event
may be influenced by variation in promotional fac-
tors acting at each step.
Many different disorders may affect the fre-
quency ofmutational events within specific tissues.
Tissue specific aberrations in growth control due to
an intrinsic increased mutation rate, excessive
promotional or growth stimulating factors (neuro-
fibromatosis?), or chronic stimulation due to failure
of feedback control mechanisms (immune defi-
ciency syndromes?) may lead to tissue specific in-
creased mutation rates, or increased cell prolifera-
tion and thus increased numbers of cells at risk.
Exposure of tissues with a high mutation rate to
mutagens increases the probability not only of the
first mutation, but also of subsequent mutations
leading to malignancy.
Disorders characterized by chromosomal insta-
bility or increased mutagenesis in vivo or in vitro
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may be predisposed to malignancy. This instability
may be enhanced in vivo or in vitro by exposure to
specific mutagens. The prototype for such disorders
is xeroderma pigmentosum, in which there is clear
correlation between clinical susceptibility to car-
cinogenesis in areas exposed to ultraviolet light and
in vitro inability to repair ultraviolet-induced DNA
damage.
Disorders of chromosomal instability are each
unique with specific patterns of chromosomal
breakage, in vitro mutagenesis, and predisposition
to malignancy. In Fanconi's anemia, there is pri-
mary bone marrow failure, increased chromosomal
breakage in vivo and in vitro, increased sensitivity
to certain mutagens in vitro, and a predisposition to
leukemia; also there may be a predisposition to
hepatoma, enhanced by androgen therapy or
transfusion-induced cirrhosis, and a predisposition
to squamous cell carcinoma. In Bloom's syndrome
there is an immune deficiency, increased sensitivity
to mutagenesis in vitro as evidenced by increased
sister chromatid exchanges, and an increased inci-
dence of leukemia and of other tumors including
squamous cell carcinoma and cancer ofthe colon at
an early age. In ataxia telangiectasia there are de-
fects in the immune system, in vivo and in vitro
sensitivity to ionizing radiation, and an increased
incidence of leukemia, lymphoma, ovarian and
gastric carcinoma. There is a tendency toward
chromosomal rearrangement specifically affecting
the number 14 chromosome including in vivo clonal
proliferation which may evolve to malignancy.
Chromosomal instability may provide a marker
for cells with increased mutation rates. In addition
to the autosomal recessive disorders described
above, aneuploidy, as in Down's syndrome, may
increase susceptibility to certain mutagens in vitro,
and may predispose to leukemia. Certain "cancer-
prone" families demonstrate chromosomal insta-
bility as well.
There may be a genetically determined increased
risk ofmutation (and cancer) following exposure to
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termined metabolism of that given agent. The bril-
liant work of Ames and co-workers has de-
monstrated that ultimate or active carcinogens are
in general mutagens, but that many chemicals with
in vivo carcinogenic properties mustbe metabolized
in vivo to their active form. In at least one such
system, the aryl hydrocarbon hydroxylase system
involved in metabolism ofpolycyclic hydrocarbons,
genetic variation has been reported. Inducibility of
the enzyme system has been associated with in-
creased risk of lung cancer in smokers. Although
these data have not been confirmed, this system
may serve as a model whereby the risk of cancer
following exposure to an environmental agent may
be modified according to the genetically determined
metabolism of that agent.
If malignancy is indeed the result of sequential
mutations, one or more of which may be inherited,
then there maybe apopulation who is susceptible to
mutagenesis not because of any increased proba-
bility that they will sustain a mutation, but because
they already carry one tissue-specific cancer-pre-
disposing mutation in all cells, and a subsequent
mutation may thus greatly increase the probability
of malignancy in that tissue.
Recent observations on the effects of a known
mutagen/carcinogen, radiation, on patients with
hereditary retinoblastoma and the nevoid basal cell
carcinoma syndrome demonstrate that individuals
with such a hereditary predisposition to malignancy
must be considered a unique subgroup with respect
to susceptibility to environmental mutagenesis. In
each case it was suggested that radiation increased
the probability of the specific tumor to which the
patients were genetically predisposed, and that the
radiation-induced tumors developed within a
uniquely short period of time. The short latent pe-
riod for radiation-induced sarcoma following
retinoblastoma, and for radiation-induced basal cell
carcinoma following medulloblastoma in patients
with the nevoid basal cell carcinoma syndrome
were not characteristic ofradiation-induced tumors
in general, in children, nor were they biologic
characteristics of radiation-induced sarcomas or
basal cell carcinomas. Indeed these data suggested
that radiation provided the second mutational step
necessary for carcinogenesis in those individuals
who had inherited the first step.
Given a sequential mutational model for cancer,
susceptible subgroups might include all individuals
who have sustained a primary mutation through a
germinal or somatic cell. Individuals who inherit the
predisposing mutation are at greatest risk because
each cell ofthe sensitive tissue(s) carries the mutant
gene, and a subsequent mutation in any cell may
lead to malignancy. However, this model as well
accounts for the synergistic, multiplicative effects
of mutagens on the risk of cancer in general. Per-
sons who have been exposed to radiation or other
mutagens may be much more susceptible to sub-
sequent mutagens due to their previous acquisition
of a cancer predisposing mutation.
In those individuals who acquire the first muta-
tion in a somatic cell, promotional factors may be
critical in the probability of cancer. Any factor, en-
dogenous or exogenous, including growth
stimulating factors, hormones, drugs, depressed
immune system, etc., which might give the mutant
cell an advantage may increase the probability of
malignancy. Immune deficiency syndromes may be
viewed in the classical manner as a breakdown in
immunosurveillance producing a general promo-
tional effect through failure to recognize or elimi-
nate the mutant cell, or as representing a tissue
specific defect in growth regulation of the lym-
phoreticular system.
Study of subgroups genetically susceptible to
carcinogenesis and definition of the mechanism of
their susceptibility is critical to any attempt to ex-
trapolate datafrom animal to man orfrom high dose
to low dose responses. Even if carcinogenesis can
be reduced to a simple multistep mutational model,
man is not homogeneous with respect to mutation
rates, elimination of mutant cells, growth control,
metabolism ofpotential mutagens, or the number of
mutational steps necessary for malignancy. Study
of each uniquely susceptible subgroup may
contribute to ourunderstanding ofcarcinogenesis in
general, and may provide complementary in vitro
systemsforthe evaluationofpotentialcarcinogens.
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